Thank you to all of you who completed PHCN’s grazoprevir / elbasvir patient input survey and the earlier Technivie patient input survey. Thank you also for sharing them with others. It was truly an honour to read your responses and to use them to write the patient group input report for the Canadian Agency for Drugs and Technologies in Health (CADTH) on your behalf.
The patient group input reports requested by CADTH are an important step towards getting new treatments for hep C more widely available in Canada and BC.
The patient input about grazoprevir / elbasvir was sent in this morning. We now wait to hear the outcome of the treatment submissions.
The Hepatitis C Treatment Information Project will keep you apprised of any news and is here to answer any questions you may have.
Thank you for taking the time to voice your opinion and help advocate for a better tomorrow.